Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Open in Screener

IMRX

Immuneering Corp

May 17 • 04:00PM ET

1.47

Dollar change -0.07
Percentage change -4.55	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWO CNCR VTWO IWC IWN VTWG AVSC

Index	RUT	P/E	-	EPS (ttm)	-1.86	Insider Own	29.16%	Shs Outstand	29.27M	Perf Week	1.38%
Market Cap	43.59M	Forward P/E	-	EPS next Y	-1.77	Insider Trans	-11.40%	Shs Float	21.00M	Perf Month	-16.95%
Income	-54.18M	PEG	-	EPS next Q	-0.52	Inst Own	34.78%	Short Float	15.28%	Perf Quarter	-77.73%
Sales	0.00M	P/S	-	EPS this Y	-3.66%	Inst Trans	-2.73%	Short Ratio	4.10	Perf Half Y	-72.16%
Book/sh	2.65	P/B	0.55	EPS next Y	8.95%	ROA	-55.37%	Short Interest	3.21M	Perf Year	-83.03%
Cash/sh	2.40	P/C	0.61	EPS next 5Y	-	ROE	-61.38%	52W Range	1.38 - 11.92	Perf YTD	-80.00%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-57.97%	ROI	-65.42%	52W High	-87.67%	Beta	-0.54
Dividend TTM	-	Quick Ratio	14.38	Sales past 5Y	-43.59%	Gross Margin	-168734.95%	52W Low	6.52%	ATR (14)	0.18
Dividend Ex-Date	-	Current Ratio	14.38	EPS Y/Y TTM	4.19%	Oper. Margin	0.00%	RSI (14)	34.26	Volatility	7.61% 9.92%
Employees	68	Debt/Eq	0.06	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.75	Target Price	13.07
Option/Short	No / Yes	LT Debt/Eq	0.05	EPS Q/Q	5.31%	Payout	-	Rel Volume	0.24	Prev Close	1.54
Sales Surprise	-	EPS Surprise	2.57%	Sales Q/Q	-	Earnings	May 07 AMC	Avg Volume	782.03K	Price	1.47
SMA20	-6.16%	SMA50	-39.03%	SMA200	-75.38%	Trades		Volume	183,913	Change	-4.55%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-15-24	Reiterated	Needham	Buy	$20 → $15
Mar-15-24	Downgrade	TD Cowen	Outperform → Market Perform
Mar-15-24	Downgrade	Jefferies	Buy → Hold	$16 → $3
Dec-01-23	Initiated	Needham	Buy	$20
Jun-26-23	Resumed	Oppenheimer	Outperform	$25
Apr-19-23	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$5 → $14
Apr-19-23	Upgrade	Mizuho	Neutral → Buy	$10 → $20
Mar-30-23	Initiated	Mizuho	Neutral	$10
Feb-03-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$12 → $5
Jul-08-22	Initiated	Chardan Capital Markets	Buy	$18
Apr-01-22	Initiated	Oppenheimer	Outperform	$25
Jan-07-22	Initiated	Piper Sandler	Overweight	$41

Show Previous Ratings

May-17-24 12:50PM	Early Detection Breakthrough: Biotech Companies Lead the Way in Pancreatic Cancer Treatment (PR Newswire)
May-07-24 10:55PM	IMRX Stock Earnings: Immuneering Misses EPS for Q1 2024 (InvestorPlace) -5.45%
04:05PM	Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
May-06-24 04:30PM	Immuneering Recognizes Melanoma Awareness Month (GlobeNewswire)
Apr-09-24 12:00PM	IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models (GlobeNewswire)
04:05PM	Loading…
Apr-03-24 04:05PM	Immuneering to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-27-24 08:00AM	Immuneering Announces First Patient Dosed in its Phase 1/2a Trial of IMM-6-415 to Treat Advanced Solid Tumors with RAF or RAS Mutations (GlobeNewswire)
Mar-18-24 11:02AM	Immuneering (IMRX) Plummets 71% in One Week: Here's Why (Zacks) +34.03%
Mar-14-24 07:00AM	Immuneering Announces Positive Topline Results from Phase 1 Portion of its Phase 1/2a Clinical Trial of IMM-1-104 in RAS-Mutant Solid Tumors (GlobeNewswire) -50.68%
Mar-12-24 08:00AM	Immuneering Appoints Thomas J. Schall, Ph.D. to its Board of Directors (GlobeNewswire)
Mar-11-24 08:00AM	Immuneering Doses First Patient in Phase 2a Clinical Trial of IMM-1-104 in RAS-mutant Solid Tumors (GlobeNewswire) -9.53%
Mar-06-24 08:00AM	Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning (Newsfile)
Mar-05-24 05:00PM	Immuneering to Present Preclinical Data on Universal-RAS Program IMM-1-104 at American Association for Cancer Research Annual Meeting 2024 (GlobeNewswire)
Mar-04-24 08:00AM	Immuneering to Participate in the Cowen 44th Annual Health Care Conference (GlobeNewswire)
Mar-03-24 07:01PM	Immuneering Corp (IMRX) Reports Q4 and Full Year 2023 Financial Results (GuruFocus.com)
08:00AM	Loading…
Mar-01-24 08:00AM	Immuneering Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Feb-20-24 08:00AM	Immuneering Receives FDA Fast Track Designation for IMM-1-104 in Pancreatic Cancer (GlobeNewswire)
Feb-14-24 03:45PM	3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave (InvestorPlace) +8.00%
Feb-01-24 08:00AM	Immuneering Announces Participation in February Investor Conferences (GlobeNewswire)
Dec-12-23 08:00AM	Immuneering Announces FDA Clearance of IND Application for Phase 1/2a Trial of IMM-6-415 to Treat Advanced Solid Tumors with RAF or RAS Mutations (GlobeNewswire) -7.11%
Nov-20-23 04:05PM	Immuneering to Present at the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-09-23 04:05PM	Immuneering Reports Third Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire) -11.86%
Oct-12-23 04:05PM	Immuneering Presents Preclinical Data Demonstrating Encouraging Anti-Tumor Activity for IMM-1-104 and IMM-6-415 at AACR-NCI-EORTC Conference (GlobeNewswire) -6.65%
Oct-04-23 04:05PM	Immuneering to Present Preclinical Data on IMM-1-104 and IMM-6-415 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire)
Sep-06-23 08:00AM	Immuneering to Present at the Morgan Stanley Healthcare Conference (GlobeNewswire)
Aug-03-23 04:05PM	Immuneering Reports Second Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Aug-02-23 06:09AM	Immuneering Corporation (NASDAQ:IMRX) insiders have significant skin in the game with 28% ownership (Simply Wall St.)
Jul-05-23 09:55AM	Wall Street Analysts Think Immuneering Corporation (IMRX) Could Surge 103.8%: Read This Before Placing a Bet (Zacks)
Jun-05-23 08:00AM	Immuneering Completes Dose Escalation in the IMM-1-104 Phase 1 Clinical Trial for RAS-Mutant, Advanced Solid Tumors (GlobeNewswire)
May-30-23 08:00AM	Immuneering to Present at the Jefferies Healthcare Conference (GlobeNewswire) +6.86%
07:25PM	Loading…
May-04-23 07:25PM	Immuneering Corporation (IMRX) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -8.75%
04:05PM	Immuneering Reports First Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Apr-18-23 09:24AM	Immuneering Announces $30 Million Underwritten Offering (GlobeNewswire) +9.60%
09:00AM	Immuneering Announces Positive Initial Phase 1 Pharmacokinetic, Pharmacodynamic and Safety Data for IMM-1-104 Universal-RAS Program; Accelerates Study Timeline (GlobeNewswire)
04:20AM	Morphic Holding, Inc. (MORF) Moves 22.5% Higher: Will This Strength Last? (Zacks)
Apr-12-23 04:05PM	Immuneering to Present at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-11-23 03:56AM	Immuneering Corporation (IMRX) Surges 18.5%: Is This an Indication of Further Gains? (Zacks) +5.78%
Apr-05-23 08:00AM	Immuneering to Present Initial Phase 1 Pharmacokinetic, Pharmacodynamic Modeling and Safety Data for Universal-RAS Program IMM-1-104 at American Association for Cancer Research Annual Meeting 2023 (GlobeNewswire)
Mar-28-23 08:00AM	Immuneering Appoints Harold E. Brakewood as Chief Business Officer (GlobeNewswire) -7.40%
Mar-27-23 09:55AM	Wall Street Analysts Believe Immuneering Corporation (IMRX) Could Rally 102.51%: Here's is How to Trade (Zacks)
Mar-24-23 01:25PM	Why Shares of Immuneering Jumped This Week (Motley Fool)
Mar-23-23 06:18AM	Immuneering Corporation (IMRX) Soars 16.9%: Is Further Upside Left in the Stock? (Zacks)
Mar-14-23 04:30PM	Immuneering to Present Data on Universal-RAS Program IMM-1-104 at American Association for Cancer Research Annual Meeting 2023 (GlobeNewswire) +5.62%
Mar-09-23 09:55AM	Does Immuneering Corporation (IMRX) Have the Potential to Rally 210.19% as Wall Street Analysts Expect? (Zacks) +5.47%
Mar-08-23 07:14AM	Immuneering Corporation (NASDAQ:IMRX) Q4 2022 Earnings Call Transcript (Insider Monkey) +22.87%
Mar-06-23 05:45PM	Immuneering Corporation (IMRX) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Immuneering Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates (GlobeNewswire)
Mar-05-23 06:30PM	Immuneering Presents Preclinical Data with Lead Program IMM-1-104 Supporting Universal-RAS Activity (GlobeNewswire)
Feb-28-23 08:00AM	Immuneering Announces Participation in March Investor Conferences (GlobeNewswire)
Feb-27-23 08:00AM	Immuneering to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates (GlobeNewswire)
Feb-05-23 07:18AM	Immuneering Corporation (NASDAQ:IMRX) insiders, who hold 31% of the firm would be disappointed by the recent pullback (Simply Wall St.)
Jan-31-23 06:50AM	Immuneering To Present at Guggenheim 2023 Oncology Conference (GlobeNewswire)
Nov-28-22 06:50AM	Immuneering Announces First Patient Dosed in its Phase 1/2a Clinical Trial of IMM-1-104 in Advanced Solid Tumors with RAS Mutations (GlobeNewswire)
Nov-16-22 06:35AM	Immuneering Third Quarter 2022 Earnings: Revenues Disappoint (Simply Wall St.)
Nov-10-22 10:15AM	Immuneering Corporation (IMRX) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
09:00AM	Immuneering Reports Third Quarter 2022 Financial Results and Recent Business Highlights (GlobeNewswire)
09:00AM	Immuneering Presents Promising Preclinical Data on its Second Program IMM-6-415 at the 37th Annual Meeting of SITC (GlobeNewswire)
Nov-03-22 06:50AM	Immuneering Announces Participation in November Investor Conferences (GlobeNewswire) -12.80%
Oct-20-22 06:50AM	Immuneering Appoints Leah R. Neufeld as Chief People Officer (GlobeNewswire)
Oct-05-22 08:05AM	Immuneering To Present Poster on IMM-6-415 at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) (GlobeNewswire) -5.80%
Sep-30-22 12:00PM	What Makes Immuneering Corporation (IMRX) a New Buy Stock (Zacks) +9.15%
06:50AM	Immuneering Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of IMM-1-104 to Treat Advanced Solid Tumors with RAS Mutations (GlobeNewswire)
Sep-12-22 09:55AM	Wall Street Analysts See a 148% Upside in Immuneering Corporation (IMRX): Can the Stock Really Move This High? (Zacks) +10.82%
Sep-05-22 10:21AM	Immuneering (IMRX) Files IND for Cancer Candidate IMM-1-104 (Zacks)
Sep-02-22 08:09AM	Immuneering Announces Submission of IND Application to the FDA for Phase 1/2a Trial of IMM-1-104 to Treat Advanced Solid Tumors with RAS Mutations (GlobeNewswire) +7.05%
Aug-25-22 09:55AM	Wall Street Analysts Believe Immuneering Corporation (IMRX) Could Rally 224%: Here's is How to Trade (Zacks) -7.35%
06:50AM	Immuneering Announces Participation in September Investor Conferences (GlobeNewswire)
Aug-10-22 05:55PM	Immuneering Corporation (IMRX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Immuneering Reports Second Quarter 2022 Financial Results and Recent Business Highlights (GlobeNewswire)
Aug-08-22 12:24PM	Immuneering (NASDAQ:IMRX) shareholders have endured a 77% loss from investing in the stock a year ago (Simply Wall St.) +11.25%
Jul-22-22 10:01AM	Lumos (LUMO) Soars 9.4%: Is Further Upside Left in the Stock? (Zacks)
Jul-11-22 07:57AM	What Type Of Shareholders Own The Most Number of Immuneering Corporation (NASDAQ:IMRX) Shares? (Simply Wall St.)
Jul-08-22 11:40AM	Why This Small-Cap Stock Is Gaining More Than 10% Today? (Benzinga) +28.85%
Jul-06-22 06:50AM	Immuneering Announces Participation in William Blair Biotech Focus Conference 2022 (GlobeNewswire) +5.80%
May-26-22 05:26PM	Immuneering Reports Data in Two Preclinical Abstracts at the ASCO 2022 Annual Meeting Highlighting Pan-KRAS/NRAS Activity of IMM-1-104 (GlobeNewswire) +11.31%
May-20-22 06:50AM	Immuneering Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
May-10-22 06:30AM	Immuneering Reports First Quarter 2022 Financial Results and Recent Business Highlights (GlobeNewswire) +13.99%
May-09-22 08:54AM	Immuneering Corporation (NASDAQ:IMRX) insiders placed bullish bets worth US$10.0m in the last 12 months (Simply Wall St.) -12.63%
May-05-22 06:50AM	Immuneering Announces Participation in Citis Biopharma VIRTUAL Co-Panel Day (GlobeNewswire) -8.36%
Apr-07-22 10:46AM	Oppenheimer Sees Gains of Over 100% in These 3 Beaten-Down Stocks (TipRanks) +5.09%
Apr-01-22 06:50AM	Immuneering Announces Participation in Piper Sandler AI/ML Investor Conference (GlobeNewswire) +14.99%
Mar-24-22 06:55AM	Immuneering Announces Participation in the 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-10-22 08:46AM	Is a Surprise Coming for Immuneering (IMRX) This Earnings Season? (Zacks)
06:30AM	Immuneering Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates (GlobeNewswire)
Feb-24-22 06:50AM	Immuneering Announces Participation in March Investor Conferences (GlobeNewswire) +5.46%
Feb-07-22 08:30AM	Should You Buy Immuneering (IMRX) Ahead of Earnings? (Zacks)
Jan-31-22 12:24PM	What Is The Ownership Structure Like For Immuneering Corporation (NASDAQ:IMRX)? (Simply Wall St.)
Jan-24-22 06:50AM	Immuneering Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
Jan-19-22 08:00AM	PepGen Appoints Laurie Keating as Chair of Board of Directors (GlobeNewswire)
Jan-18-22 06:50AM	Immuneering Strengthens Board of Directors with the Appointment of Diana F. Hausman, M.D. (GlobeNewswire)
Jan-06-22 04:10PM	Immuneering Reports Compelling Preclinical Data on IMM-1-104 in NRAS Mutant Melanoma Model And Will Host Key External Expert Investor Event (GlobeNewswire) -8.66%
Jan-03-22 06:50AM	Immuneering Appoints Rimma Steinhertz, Ph.D., PMP as Vice President, Project and Alliance Management (GlobeNewswire) +5.07%
Dec-16-21 06:50AM	Immuneering Added to the Nasdaq Biotechnology Index (GlobeNewswire)
Nov-18-21 06:35AM	Immuneering Announces Participation in December Investor Conferences (GlobeNewswire)
Nov-10-21 06:50AM	Immuneering to Participate in Jefferies 2021 London Healthcare Conference (GlobeNewswire)
Nov-09-21 06:30AM	Immuneering Reports Third Quarter 2021 Financial Results and Recent Business Highlights (GlobeNewswire)
Nov-01-21 09:20AM	Companies Like Immuneering (NASDAQ:IMRX) Are In A Position To Invest In Growth (Simply Wall St.)
Oct-11-21 06:50AM	Immuneering Reports Compelling Preclinical Data on IMM-1-104 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire) -18.44%
Oct-01-21 06:50AM	Immuneering to Present Key Preclinical Data Across Several Poster Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire) +8.85%
Sep-20-21 04:10PM	Immuneering Announces Inclusion in the Russell 2000® Index (GlobeNewswire) -11.27%

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Cormorant Asset Management, LP	10% Owner	Apr 01 '24	Sale	2.90	400,000	1,160,181	2,895,273	Apr 03 05:37 PM
Feinberg Peter	Director	Mar 22 '24	Buy	2.55	25,000	63,713	111,766	Mar 25 09:13 AM
Brakewood Harold Eugene	Chief Business Officer	Mar 22 '24	Buy	2.57	3,900	10,015	3,900	Mar 25 09:10 AM
Schall Thomas J.	Director	Mar 22 '24	Buy	2.55	2,900	7,385	2,900	Mar 25 04:03 PM
Morales Mallory	Chief Accounting Officer	Mar 22 '24	Buy	2.55	393	1,000	8,278	Mar 25 09:04 AM
Morales Mallory	Chief Accounting Officer	Mar 21 '24	Buy	2.72	1,107	3,009	7,885	Mar 25 09:04 AM
Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	Mar 20 '24	Buy	2.86	7,000	20,020	345,896	Mar 21 09:06 AM
Neufeld Leah R	CHIEF PEOPLE OFFICER	Mar 20 '24	Buy	2.88	3,818	10,993	10,029	Mar 21 09:11 AM
Feinberg Peter	Director	Mar 19 '24	Buy	2.56	25,000	64,000	86,766	Mar 19 07:04 PM
Zeskind Benjamin J.	PRESIDENT AND CEO	Mar 19 '24	Buy	2.77	20,000	55,326	2,281,852	Mar 19 06:59 PM
BERMAN ANN E	Director	Mar 18 '24	Buy	2.13	57,965	123,436	67,465	Mar 19 07:10 PM
Feinberg Peter	Director	Mar 18 '24	Buy	2.38	50,000	119,058	61,766	Mar 19 07:04 PM
Cormorant Asset Management, LP	10% Owner	Mar 15 '24	Sale	2.14	400,000	856,400	3,295,273	Mar 18 05:59 PM
Cormorant Asset Management, LP	10% Owner	Mar 14 '24	Sale	3.72	509,091	1,892,603	3,695,273	Mar 18 05:59 PM

Open in Screener

L

Loews Corp.

May 17 • 04:00PM ET

77.74

Dollar change +0.54
Percentage change 0.70	%

Financial • Insurance - Property & Casualty • USA • NYSE

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO VO IVV VTV RSP VOE SPLV USMV IWR

Index	S&P 500	P/E	11.55	EPS (ttm)	6.73	Insider Own	17.32%	Shs Outstand	222.17M	Perf Week	-0.31%
Market Cap	17.21B	Forward P/E	-	EPS next Y	-	Insider Trans	-1.87%	Shs Float	183.07M	Perf Month	5.28%
Income	1.52B	PEG	0.82	EPS next Q	-	Inst Own	59.50%	Short Float	0.99%	Perf Quarter	4.57%
Sales	16.30B	P/S	1.06	EPS this Y	-	Inst Trans	-3.46%	Short Ratio	2.56	Perf Half Y	16.85%
Book/sh	72.87	P/B	1.07	EPS next Y	-	ROA	1.93%	Short Interest	1.81M	Perf Year	33.48%
Cash/sh	-	P/C	-	EPS next 5Y	14.03%	ROE	9.90%	52W Range	55.94 - 78.55	Perf YTD	11.71%
Dividend Est.	-	P/FCF	6.21	EPS past 5Y	25.93%	ROI	6.16%	52W High	-1.03%	Beta	0.85
Dividend TTM	0.25 (0.32%)	Quick Ratio	-	Sales past 5Y	2.70%	Gross Margin	-	52W Low	38.97%	ATR (14)	0.92
Dividend Ex-Date	May 29, 2024	Current Ratio	0.66	EPS Y/Y TTM	53.03%	Oper. Margin	14.27%	RSI (14)	58.33	Volatility	0.98% 1.16%
Employees	12280	Debt/Eq	0.62	Sales Y/Y TTM	13.02%	Profit Margin	9.30%	Recom	3.00	Target Price	52.00
Option/Short	Yes / Yes	LT Debt/Eq	0.52	EPS Q/Q	27.79%	Payout	3.97%	Rel Volume	1.21	Prev Close	77.20
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	11.84%	Earnings	May 06 BMO	Avg Volume	708.42K	Price	77.74
SMA20	1.31%	SMA50	1.90%	SMA200	11.60%	Trades		Volume	855,154	Change	0.70%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-02-16	Reiterated	Deutsche Bank	Hold	$42 → $43
Aug-06-15	Reiterated	Deutsche Bank	Hold	$48 → $44
Mar-24-14	Downgrade	Deutsche Bank	Buy → Hold	$53 → $51
Sep-04-13	Initiated	Deutsche Bank	Buy	$52
Jun-23-09	Initiated	Susquehanna Financial	Positive

May-14-24 10:41AM	LOEWS CORPORATION ANNOUNCES QUARTERLY DIVIDEND ON COMMON STOCK (PR Newswire)
May-07-24 05:01PM	Loews Corp (L) (Q1 2024) Earnings Call Transcript Highlights: Strong Performance with Notable ... (GuruFocus.com)
09:53AM	CNA Financial Corporation (NYSE:CNA) Q1 2024 Earnings Call Transcript (Insider Monkey)
01:03AM	Decoding Loews Corp (L): A Strategic SWOT Insight (GuruFocus.com)
May-06-24 10:53AM	L Stock Earnings: Loews Reported Results for Q1 2024 (InvestorPlace)
10:20AM	Loading…
10:20AM	The Marcus Corporation (NYSE:MCS) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:02AM	Loews Corp (L) Reports Strong First Quarter 2024 Earnings, Net Income Rises 22% (GuruFocus.com)
07:02AM	Loews reports higher profit on strong returns on investment income (Reuters)
06:08AM	Loews: Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $457 MILLION FOR THE FIRST QUARTER OF 2024 (PR Newswire)
May-03-24 06:00AM	Loblaw Releases 2023 ESG Report (PR Newswire)
Apr-16-24 10:00AM	Loews Corporation to Release First Quarter 2024 Results on May 6, 2024 (PR Newswire)
Mar-06-24 11:29PM	Senior Vice President Kenneth Siegel Sells 6,322 Shares of Loews Corp (L) (GuruFocus.com)
Feb-13-24 11:30AM	Loews Arlington Hotel and Convention Center Officially Opens Its Doors (PR Newswire)
Feb-06-24 11:31AM	LOEWS CORPORATION ANNOUNCES QUARTERLY DIVIDEND ON COMMON STOCK (PR Newswire)
08:41AM	Loading…
08:41AM	CNA Financial Corporation (NYSE:CNA) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:14AM	Loews Corporation (NYSE:L) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-05-24 04:19PM	Loews Hotels Pursues $435 Million Expansion in Texas and Florida (Skift)
07:01AM	Loews Corp (L) Reports Strong Earnings Growth in Q4 and Full Year 2023 (GuruFocus.com)
06:59AM	Loews fourth-quarter profit jumps on investment income gains (Reuters)
06:25AM	Loews: Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $446 MILLION FOR THE FOURTH QUARTER OF 2023 AND $1.4 BILLION FOR THE FULL YEAR (PR Newswire)
Jan-16-24 10:00AM	Loews Corporation to Release Fourth Quarter 2023 Results on February 5, 2024 (PR Newswire)
Dec-13-23 10:28AM	15 Best Property and Casualty Insurance Companies Heading into 2024 (Insider Monkey)
Dec-02-23 03:05AM	Insider Sell Alert: Kenneth Siegel Offloads Shares of Loews Corp (GuruFocus.com)
Nov-13-23 10:00AM	Inside Amazon's robot empire (Yahoo Finance Video)
Nov-07-23 11:46AM	LOEWS CORPORATION ANNOUNCES QUARTERLY DIVIDEND ON COMMON STOCK (PR Newswire)
Nov-06-23 01:13AM	Buffett sells BYD shares; a 51% WeWork bid: Insider trades & hedge funds weekly (Investing.com)
Nov-02-23 01:04AM	Director Jonathan Locker Buys 15,870 Shares of Loews Corp (GuruFocus.com)
Oct-30-23 08:12AM	Loews Corp (L) Reports Q3 2023 Net Income of $253 Million (GuruFocus.com)
07:19AM	Loading…
07:19AM	Loews posts Q3 profit on higher investment income, insurance premium (Reuters)
06:11AM	Loews: Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $253 MILLION FOR THE THIRD QUARTER OF 2023 (PR Newswire)
04:04AM	McDonald's, Ford, Southwest Airlines rise premarket; Cisco fell (Investing.com)
Oct-10-23 10:00AM	Loews Corporation to Release Third Quarter 2023 Results on October 30, 2023 (PR Newswire)
Sep-29-23 02:03PM	These 3 Insurance Stocks Trade Below Book and Pay Dividends (GuruFocus.com)
Sep-19-23 10:08AM	Loews Corporation Elects Jonathan Locker to Its Board of Directors (PR Newswire)
Sep-13-23 08:00AM	Loews Stock Tops Buy Point, A Stone's Throw From All-Time High (Investor's Business Daily)
Aug-01-23 12:04PM	LOEWS CORPORATION ANNOUNCES QUARTERLY DIVIDEND ON COMMON STOCK (PR Newswire)
06:27AM	Is Now The Time To Put Loews (NYSE:L) On Your Watchlist? (Simply Wall St.)
Jul-31-23 07:08AM	Loews profit more than doubles as market rebound boosts investment returns (Reuters)
06:07AM	Loews: Q2 Earnings Snapshot (AP Finance)
06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $360 MILLION FOR THE SECOND QUARTER OF 2023 (PR Newswire)
Jul-11-23 10:00AM	Loews Corporation to Release Second Quarter 2023 Results on July 31, 2023 (PR Newswire)
Jul-09-23 08:20AM	With 59% institutional ownership, Loews Corporation (NYSE:L) is a favorite amongst the big guns (Simply Wall St.)
Jul-07-23 10:10AM	3 Stocks to Snag for Less Than Book Value (InvestorPlace)
Jun-21-23 08:00PM	L: Lowering target price to $61.00 (Argus Research)
Jun-11-23 03:35AM	5 hot insider trades & hedge fund hits: Cathie Wood snaps up more Coinbase (Investing.com)
Jun-05-23 06:44AM	Daily Vickers Top Buyers & Sellers for 06/05/2023 (Argus Research)
Jun-04-23 08:08AM	Loews Senior VP of Corporate Development & Strategy Acquires 1,625% More Stock \ (Simply Wall St.)
Jun-02-23 12:11PM	10 Best Property & Casualty Insurance Stocks to Buy (Insider Monkey)
May-09-23 08:36AM	LOEWS CORPORATION ANNOUNCES QUARTERLY DIVIDEND ON COMMON STOCK (PR Newswire)
May-08-23 08:38AM	Are Loews Corporation's (NYSE:L) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? (Simply Wall St.)
May-01-23 04:26PM	S&P 500: Nvidia Stock Is A Top Performer, While Regional Banks Skid (Investor's Business Daily)
06:11AM	Loews: Q1 Earnings Snapshot (AP Finance)
06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $375 MILLION FOR THE FIRST QUARTER OF 2023 (PR Newswire)
Apr-26-23 08:00PM	L: Rating increased to a BUY (Argus Research)
Apr-18-23 07:00AM	Loblaw Companies Limited Announces Senior Management Changes, Effective By Q1 2024 (PR Newswire)
Apr-11-23 10:00AM	Loews Corporation to Release First Quarter 2023 Results on May 1, 2023 (PR Newswire)
Mar-24-23 07:30AM	Loblaw Companies Limited Enters into Automatic Share Purchase Plan (PR Newswire)
Mar-20-23 07:33AM	Loews' (NYSE:L) three-year total shareholder returns outpace the underlying earnings growth (Simply Wall St.)
Feb-08-23 07:20PM	Loews Stock Cools In Sync With Market After Strong Recent Gains (Investor's Business Daily)
Feb-06-23 06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $364 MILLION FOR THE FOURTH QUARTER OF 2022 AND $1.0 BILLION FOR THE FULL YEAR (PR Newswire)
Jan-29-23 09:19AM	A great week that adds to Loews Corporation's (NYSE:L) one-year returns, institutional investors who own 61% must be happy (Simply Wall St.)
Jan-24-23 10:00AM	Loews Corporation to Release Fourth Quarter 2022 Results on February 6, 2023 (PR Newswire)
12:00AM	US court reins in the questioning of the intent of corporate lawyers (Financial Times)
Dec-20-22 11:20AM	Loews Wins Appeal Over $690 Million Damages Award to Hedge Fund (Bloomberg)
Nov-28-22 01:10PM	Loews Corporation's (NYSE:L) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock? (Simply Wall St.)
Nov-08-22 06:04AM	Loews Third Quarter 2022 Earnings: EPS: US$0.54 (vs US$0.86 in 3Q 2021) (Simply Wall St.)
Nov-03-22 11:32AM	LOEWS CORAL GABLES OFFICIALLY OPENS ITS DOORS (PR Newswire)
Oct-31-22 06:20AM	Loews Hotels & Co Appoints Alex Tisch CEO (PR Newswire)
06:10AM	Loews Corporation announces management changes at Loews Hotels & Co: Jonathan Tisch to assume Executive Chairman Position; Alex Tisch to become President and CEO (PR Newswire)
06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $130 MILLION FOR THE THIRD QUARTER OF 2022 (PR Newswire)
Oct-18-22 10:05AM	Loews Corporation to Release Third Quarter 2022 Results on October 31, 2022 (PR Newswire)
Oct-10-22 01:43PM	The past one-year earnings decline for Loews (NYSE:L) likely explains shareholders long-term losses (Simply Wall St.)
Aug-22-22 08:22AM	With 62% ownership of the shares, Loews Corporation (NYSE:L) is heavily dominated by institutional owners (Simply Wall St.)
Aug-19-22 09:13AM	Altium Packaging LLC -- Moody's says Altium's ratings not impacted by senior secured term loan add-on (Moody's)
Aug-07-22 10:30AM	Bearish Bets: 3 Stocks You Really Should Consider Shorting This Week (TheStreet.com)
Aug-01-22 06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $180 MILLION FOR THE SECOND QUARTER OF 2022 (PR Newswire)
Jul-20-22 11:30AM	Loews Hotels & Co Tops Off the $550 Million, 888-room Loews Arlington Hotel and Arlington Convention Center and Names Soy Cowboy as Hotel's Signature Restaurant Anchor (PR Newswire)
Jul-19-22 10:14AM	Loews Corporation to Release Second Quarter 2022 Results on August 1, 2022 (PR Newswire)
Jun-19-22 08:27AM	Should Weakness in Loews Corporation's (NYSE:L) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? (Simply Wall St.)
May-10-22 12:00PM	Loews Corporation Promotes Benjamin Tisch to Senior Vice President, Corporate Development and Strategy (PR Newswire)
May-03-22 12:38PM	Loews' (NYSE:L) earnings growth rate lags the 6.2% CAGR delivered to shareholders (Simply Wall St.)
May-02-22 06:12AM	Loews earnings rise, but revenue falls as investment income swings to negative due to rise in interest rates (MarketWatch)
06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $338 MILLION FOR THE FIRST QUARTER OF 2022 (PR Newswire)
Apr-19-22 10:00AM	Loews Corporation to Release First Quarter 2022 Results on May 2, 2022 (PR Newswire)
Apr-07-22 07:00AM	Loblaw leading the way with sustainable packaging on PC® and no name® coffee products (PR Newswire)
Apr-06-22 01:28PM	Loblaw Companies Limited (TSE:L) Shares Could Be 27% Above Their Intrinsic Value Estimate (Simply Wall St.)
06:30AM	Loblaw Companies Limited Announces the Timing of the First Quarter 2022 Earnings Release and Annual Meeting of Shareholders (PR Newswire)
Apr-05-22 02:03PM	Downtown D.C. hotel sells for $61 million (American City Business Journals)
Mar-30-22 11:29AM	Loews Corp: Diversified Holding Company Appears Undervalued (GuruFocus.com)
Mar-25-22 05:00PM	Loblaw Companies Limited Enters into Automatic Share Purchase Plan (PR Newswire)
Mar-23-22 06:23AM	Loblaw takes action on climate change with net-zero commitment (PR Newswire)
Mar-15-22 12:54PM	Do Institutions Own Loews Corporation (NYSE:L) Shares? (Simply Wall St.)
Feb-09-22 02:37PM	Memphis Tourism CEO Kevin Kane still bullish on hotel pipeline, even with Loews development departure (American City Business Journals)
Feb-08-22 11:42AM	Gulf South Pipeline Company, LLC -- Moody's upgrades Boardwalk Pipelines to Baa2; stable outlook (Moody's)
Feb-07-22 06:00AM	LOEWS CORPORATION REPORTS 2021 NET INCOME OF $343 MILLION FOR THE FOURTH QUARTER AND $1.6 BILLION FOR THE FULL YEAR (PR Newswire)
Feb-04-22 05:38PM	Torray LLC Buys General Motors Co, T. Rowe Price Group Inc, Applied Materials Inc, Sells Intel ... (GuruFocus.com)
Jan-25-22 10:00AM	Loews Corporation to Release Fourth Quarter 2021 Results on February 7, 2022 (PR Newswire)

Loews Corp. is a holding company, which engages in the business of commercial property and casualty insurance, transportation and storage of natural gas and natural gas liquids, and operation of a chain of hotels. It operates through the following segments: CNA Financial, Boardwalk Pipelines, Loews Hotels and Co, and Corporate. The CNA Financial segment is involved in the sale of property and casualty insurance products and services, including surety, primarily through a network of independent agents, brokers, and managing general underwriters. The Boardwalk Pipelines segment focuses on midstream portion of the natural gas and NGLs industry, providing transportation, and storage for those commodities. The Loews Hotels and Co segment refers to a chain of hotels, which are in the United States and one of which is in Canada. The Corporate segment consists of investment income from the parent company's cash and investments, parent company interest expense, and other unallocated parent company expenses. The company was founded by Laurence A. Tisch and Preston Robert Tisch on November 12, 1969 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	May 16 '24	Sale	77.14	50,000	3,857,000	457,799	May 16 05:03 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	May 14 '24	Sale	77.24	50,000	3,862,000	507,799	May 16 05:03 PM
Locker Jonathan C	Director	May 09 '24	Option Exercise	0.00	998	0	16,868	May 09 08:42 AM
WELTERS ANTHONY	Director	May 09 '24	Option Exercise	0.00	1,706	0	9,845	May 09 08:40 AM
HARRIS WALTER L	Director	May 09 '24	Option Exercise	0.00	1,706	0	22,906	May 09 08:38 AM
DIKER CHARLES M	Director	May 09 '24	Option Exercise	0.00	1,706	0	19,906	May 09 08:37 AM
DAVIDSON CHARLES D	Director	May 09 '24	Option Exercise	0.00	1,706	0	26,906	May 09 08:35 AM
BERMAN ANN E	Director	May 09 '24	Option Exercise	0.00	1,706	0	4,998	May 09 08:34 AM
TISCH ANDREW H	Director	May 09 '24	Option Exercise	0.00	1,706	0	1,726,479	May 09 08:32 AM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	May 09 '24	Sale	77.41	50,000	3,870,500	557,799	May 10 04:18 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	May 08 '24	Sale	77.39	50,000	3,869,500	607,799	May 10 04:18 PM
SIEGEL KENNETH I	Senior Vice President	Mar 06 '24	Sale	75.50	6,322	477,311	6,993	Mar 06 04:18 PM
WELTERS ANTHONY	Director	Mar 01 '24	Option Exercise	43.37	2,250	97,582	10,389	Mar 04 07:04 PM
HARRIS WALTER L	Director	Mar 01 '24	Option Exercise	43.37	2,250	97,582	23,450	Mar 04 07:02 PM
FRIBOURG PAUL J	Director	Mar 01 '24	Option Exercise	43.37	2,250	97,582	2,250	Mar 04 07:09 PM
DIKER CHARLES M	Director	Mar 01 '24	Option Exercise	43.37	2,250	97,582	20,450	Mar 04 07:07 PM
BERMAN ANN E	Director	Mar 01 '24	Option Exercise	43.37	2,250	97,582	5,542	Mar 04 04:20 PM
BOWER JOSEPH L	Director	Mar 01 '24	Option Exercise	43.37	2,250	97,582	17,300	Mar 04 04:33 PM
DIKER CHARLES M	Director	Mar 01 '24	Sale	75.02	951	71,344	18,200	Mar 04 07:07 PM
BERMAN ANN E	Director	Mar 01 '24	Sale	75.02	951	71,344	3,292	Mar 04 04:20 PM
FRIBOURG PAUL J	Director	Mar 01 '24	Sale	75.02	951	71,344	0	Mar 04 07:09 PM
HARRIS WALTER L	Director	Mar 01 '24	Sale	75.01	951	71,335	21,200	Mar 04 07:02 PM
WELTERS ANTHONY	Director	Mar 01 '24	Sale	75.01	951	71,335	8,139	Mar 04 07:04 PM
BOWER JOSEPH L	Director	Mar 01 '24	Sale	75.01	476	35,705	15,525	Mar 04 04:33 PM
SCOTT RICHARD WALDO	SVP & Chief Investment Officer	Feb 15 '24	Sale	74.12	7,325	542,929	51,965	Feb 15 05:03 PM
TISCH ANDREW H	Director	Feb 14 '24	Sale	73.30	125,000	9,162,500	820,886	Feb 15 05:05 PM
TISCH ANDREW H	Director	Feb 13 '24	Sale	73.04	125,000	9,130,000	945,886	Feb 15 05:05 PM
SIEGEL KENNETH I	Senior Vice President	Feb 08 '24	Option Exercise	0.00	7,567	0	17,500	Feb 09 04:22 PM
Tisch Benjamin J	Sr. VP, Corp Dev and Strategy	Feb 08 '24	Option Exercise	0.00	3,730	0	363,042	Feb 09 04:15 PM
Tisch Alexander H	VP; Pres. & CEO, Loews Hotels	Feb 08 '24	Option Exercise	0.00	3,730	0	37,875	Feb 09 04:17 PM
Wang Jane J.	Sr. Vice President & CFO	Feb 08 '24	Option Exercise	0.00	3,197	0	7,726	Feb 09 04:18 PM
Alpert Marc A	Sr. VP, Gen. Coun. & Secy.	Feb 08 '24	Option Exercise	0.00	7,567	0	23,872	Feb 09 04:26 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Feb 08 '24	Option Exercise	0.00	9,592	0	116,462	Feb 09 04:21 PM
SCOTT RICHARD WALDO	SVP & Chief Investment Officer	Feb 08 '24	Option Exercise	0.00	7,567	0	62,018	Feb 09 04:23 PM
SCHWARTZ MARK S	V.P., C.A.O. and Treasurer	Feb 08 '24	Option Exercise	0.00	4,743	0	19,271	Feb 09 04:25 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Feb 08 '24	Sale	71.91	4,287	308,278	106,870	Feb 09 04:21 PM
Alpert Marc A	Sr. VP, Gen. Coun. & Secy.	Feb 07 '24	Option Exercise	0.00	6,578	0	19,943	Feb 09 04:26 PM
Wang Jane J.	Sr. Vice President & CFO	Feb 07 '24	Option Exercise	0.00	4,111	0	6,803	Feb 09 04:18 PM
Tisch Alexander H	VP; Pres. & CEO, Loews Hotels	Feb 07 '24	Option Exercise	0.00	3,700	0	34,145	Feb 09 04:17 PM
Tisch Benjamin J	Sr. VP, Corp Dev and Strategy	Feb 07 '24	Option Exercise	0.00	3,700	0	359,312	Feb 09 04:15 PM
SIEGEL KENNETH I	Senior Vice President	Feb 07 '24	Option Exercise	0.00	6,578	0	13,571	Feb 09 04:22 PM
SCHWARTZ MARK S	V.P., C.A.O. and Treasurer	Feb 07 '24	Option Exercise	0.00	4,111	0	16,011	Feb 09 04:25 PM
SCOTT RICHARD WALDO	SVP & Chief Investment Officer	Feb 07 '24	Option Exercise	0.00	6,578	0	56,823	Feb 09 04:23 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Feb 07 '24	Option Exercise	0.00	8,223	0	115,093	Feb 09 04:21 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Feb 07 '24	Sale	72.69	3,675	267,136	106,870	Feb 09 04:21 PM
TISCH ANDREW H	Director	Jan 03 '24	Option Exercise	42.91	30,000	1,287,150	1,100,866	Jan 04 04:17 PM
TISCH ANDREW H	Director	Jan 03 '24	Sale	70.58	11,741	828,680	1,070,866	Jan 04 04:17 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Jan 02 '24	Option Exercise	43.94	60,000	2,636,400	166,870	Jan 04 04:16 PM
TISCH ANDREW H	Director	Jan 02 '24	Option Exercise	44.98	30,000	1,349,250	1,100,866	Jan 04 04:17 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Jan 02 '24	Sale	70.15	22,150	1,553,823	106,870	Jan 04 04:16 PM
TISCH ANDREW H	Director	Jan 02 '24	Sale	70.15	10,629	745,624	1,070,866	Jan 04 04:17 PM
BERMAN ANN E	Director	Dec 01 '23	Option Exercise	47.84	2,250	107,640	5,542	Dec 04 04:16 PM
BOWER JOSEPH L	Director	Dec 01 '23	Option Exercise	47.84	2,250	107,640	16,943	Dec 04 04:18 PM
HARRIS WALTER L	Director	Dec 01 '23	Option Exercise	47.84	2,250	107,640	23,450	Dec 04 04:22 PM
WELTERS ANTHONY	Director	Dec 01 '23	Option Exercise	47.84	2,250	107,640	10,389	Dec 04 04:23 PM
FRIBOURG PAUL J	Director	Dec 01 '23	Option Exercise	47.84	2,250	107,640	2,250	Dec 04 04:20 PM
DIKER CHARLES M	Director	Dec 01 '23	Option Exercise	47.84	2,250	107,640	20,450	Dec 04 04:19 PM
FRIBOURG PAUL J	Director	Dec 01 '23	Sale	70.21	715	50,200	0	Dec 04 04:20 PM
HARRIS WALTER L	Director	Dec 01 '23	Sale	70.17	715	50,172	21,200	Dec 04 04:22 PM
DIKER CHARLES M	Director	Dec 01 '23	Sale	70.17	715	50,172	18,200	Dec 04 04:19 PM
BERMAN ANN E	Director	Dec 01 '23	Sale	70.16	715	50,164	3,292	Dec 04 04:16 PM
WELTERS ANTHONY	Director	Dec 01 '23	Sale	70.16	715	50,164	8,139	Dec 04 04:23 PM
BOWER JOSEPH L	Director	Dec 01 '23	Sale	70.11	358	25,099	15,050	Dec 04 04:18 PM
SIEGEL KENNETH I	Senior Vice President	Nov 30 '23	Sale	70.01	6,372	446,104	6,993	Dec 01 04:18 PM
Tisch Benjamin J	Sr. VP, Corp Dev and Strategy	Nov 22 '23	Option Exercise	43.94	15,000	659,100	365,310	Nov 27 04:16 PM
TISCH ANDREW H	Director	Nov 21 '23	Sale	68.08	150,000	10,212,000	13,796,742	Nov 21 06:01 PM
TISCH ANDREW H	Director	Nov 20 '23	Sale	67.61	50,000	3,380,500	13,946,742	Nov 21 06:01 PM
Tisch Alexander H	VP, PRES & CEO, LOEWS HOTELS	Nov 17 '23	Option Exercise	43.94	15,000	659,100	40,287	Nov 20 04:15 PM
TISCH JAMES S	Pres.&Chief Exec. Officer	Nov 16 '23	Option Exercise	43.94	60,000	2,636,400	2,411,009	Nov 17 04:15 PM
Locker Jonathan C	Director	Oct 31 '23	Buy	63.75	15,870	1,011,712	15,870	Nov 01 04:15 PM
BERMAN ANN E	Director	Sep 01 '23	Option Exercise	46.99	2,250	105,728	5,542	Sep 05 04:06 PM
BOWER JOSEPH L	Director	Sep 01 '23	Option Exercise	46.99	2,250	105,728	16,663	Sep 05 04:07 PM
FRIBOURG PAUL J	Director	Sep 01 '23	Option Exercise	46.99	2,250	105,728	2,250	Sep 05 04:09 PM
HARRIS WALTER L	Director	Sep 01 '23	Option Exercise	46.99	2,250	105,728	23,450	Sep 05 04:06 PM
DIKER CHARLES M	Director	Sep 01 '23	Option Exercise	46.99	2,250	105,728	20,450	Sep 05 04:08 PM
DIKER CHARLES M	Director	Sep 01 '23	Sale	62.56	561	35,096	18,200	Sep 05 04:08 PM
BERMAN ANN E	Director	Sep 01 '23	Sale	62.56	561	35,096	3,292	Sep 05 04:06 PM
FRIBOURG PAUL J	Director	Sep 01 '23	Sale	62.56	561	35,096	0	Sep 05 04:09 PM
HARRIS WALTER L	Director	Sep 01 '23	Sale	62.55	561	35,091	21,200	Sep 05 04:06 PM
BOWER JOSEPH L	Director	Sep 01 '23	Sale	62.56	281	17,579	14,693	Sep 05 04:07 PM
DAVIDSON CHARLES D	Director	Aug 09 '23	Option Exercise	38.31	9,000	344,835	34,200	Aug 10 04:05 PM
DAVIDSON CHARLES D	Director	Aug 09 '23	Sale	63.40	3,546	224,816	25,200	Aug 10 04:05 PM
LOEWS CORP	10% Owner	Aug 02 '23	Buy	39.29	4,456,050	175,078,204	248,414,738	Aug 02 04:06 PM
SCOTT RICHARD WALDO	SVP & Chief Investment Officer	Aug 01 '23	Option Exercise	40.53	22,500	912,037	72,745	Aug 03 04:07 PM
SCOTT RICHARD WALDO	SVP & Chief Investment Officer	Aug 01 '23	Sale	62.76	8,070	506,473	50,245	Aug 03 04:07 PM
Tisch Benjamin J	Sr. VP, Corp Dev and Strategy	Jun 02 '23	Buy	57.88	110,000	6,366,800	350,310	Jun 02 05:01 PM
BERMAN ANN E	Director	Jun 01 '23	Option Exercise	44.44	2,250	99,990	5,542	Jun 02 04:48 PM
DIKER CHARLES M	Director	Jun 01 '23	Option Exercise	44.44	2,250	99,990	20,450	Jun 02 04:55 PM
BOWER JOSEPH L	Director	Jun 01 '23	Option Exercise	44.44	2,250	99,990	16,426	Jun 02 04:52 PM
FRIBOURG PAUL J	Director	Jun 01 '23	Option Exercise	44.44	2,250	99,990	2,250	Jun 02 04:57 PM
HARRIS WALTER L	Director	Jun 01 '23	Option Exercise	44.44	2,250	99,990	23,450	Jun 02 04:58 PM
Tisch Benjamin J	Sr. VP, Corp Dev and Strategy	Jun 01 '23	Buy	56.50	110,000	6,215,000	240,310	Jun 02 05:01 PM
FRIBOURG PAUL J	Director	Jun 01 '23	Sale	56.30	474	26,686	0	Jun 02 04:57 PM
DIKER CHARLES M	Director	Jun 01 '23	Sale	56.30	474	26,686	18,200	Jun 02 04:55 PM
BERMAN ANN E	Director	Jun 01 '23	Sale	56.30	474	26,686	3,292	Jun 02 04:48 PM
BOWER JOSEPH L	Director	Jun 01 '23	Sale	56.34	237	13,353	14,413	Jun 02 04:52 PM
Tisch Benjamin J	Sr. VP, Corp Dev and Strategy	May 31 '23	Buy	56.36	110,000	6,199,600	130,310	Jun 02 05:01 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

IMRX

Immuneering Corp

L

Loews Corp.

Upgrade your FINVIZ experience